PERSONAL & SCIENTIFIC PROFILE

Stasinos Chr. Sikalias

Personal and scientific profile of Stasinos Chr. Sikalias, pharmacist, leading Sikalias Pharmacy since 1998 and CEO & R&D Manager of Sikalias Pharmaceutical Laboratories.

Meet at CPHI / Start a project Publications Collaborate

The Sikalias building at 7 Kyklaminon Street, Peristeri

Scientific positioning

The same formulation question at the pharmacy bench and at industrial scale

My work connects patient-specific compounding, pharmacist-led care and health-product development through a common focus on compatibility, stability, documentation and practical implementation.

Compounding & formulation

Many compounded prescriptions are formulation challenges involving compatibility, dosage-form selection, preservation and stability.

Explore →

Pharmaceutical care

Diabetes support, medication adherence, polypharmacy and correct use of self-monitoring devices.

Explore →

Industrial R&D

Client brief, formulation and analytical development, stability, pilot work, scale-up and technical handover.

Explore →

Current work, connected to practice

SCIENTIFIC RESOURCE

Greek Formulary Sikalias

Collection and documentation of compounded preparations, edited by Stasinos Chr. Sikalias. Read the current edition and each record’s review status at compounding.gr.

Edition & authorship

PHARMACY PRACTICE

Allergen preparations

Pharmacy compounding experience in collaboration with paediatric allergists, with distinct preparation and clinical responsibilities.

Explore this field

BUSINESS DEVELOPMENT

European development dialogue

CMO, CDMO and nearshoring enquiries for complex-molecule projects and biotechnology startups, starting with a project-specific feasibility review.

Choose a collaboration route

Professional identity

Pharmacist and development leader

I am a pharmacist, leading Sikalias Pharmacy since 1998 and President, CEO & R&D Manager of Sikalias Pharmaceutical Laboratories.

My scientific foundation starts in community pharmacy and evidence-based compounding, extends into scalable formulation R&D, and returns to the patient through responsible pharmaceutical care.

Biography Scientific material

Understanding real needs and converting them into documented, workable solutions.

Current focus

Scientific collaboration with practical outcomes

Speaking & education

Compounding, pharmaceutical care, quality systems, medical devices and product development.

Explore →

Development dialogue

Formulation strategy, scale-up, manufacturing readiness and technical collaboration.

Explore →

Publications & notes

Downloadable presentations and principle-based scientific documents.

Explore →

INDUSTRIAL COLLABORATION · ATHENS, GREECE

A clear starting point for your project

CMO · Transfer & manufacturing

Bring your dossier, dosage form and forecast for a technology-transfer and manufacturing assessment.

Discuss CMO

CDMO · Development & dossier strategy

Discuss commissioned development or a dossier in preparation, with scope, rights and future manufacturing agreed for the project.

Discuss CDMO

European nearshoring

For complex-molecule projects and biotechnology startups seeking a European development or manufacturing partner. Technical fit, analytical needs and the authorised scope are assessed first.

Discuss nearshoring

R&D raw materials

Introduce an exact API, excipient, extract or functional ingredient grade for an assigned R&D project.

Introduce your materials

Quality documents

Request the current site-specific qualification package from the Laboratories’ QA team.

Request quality documents